12.04.2021

It is a pleasure to introduce our new experts

Welcome Malena, Adele, Carita, Santtu-Matti, Jussi, Katri and Miika!

07.04.2021

The Swedish Medicines Agency (MPA) is proposing increases in fees

On March 2, 2021, the MPA has proposed to the Swedish government an increase in fees for control of medicinal products as of January 1, 2022. The reason for the increases is mentioned e.g. increase in operating costs.

07.04.2021

Guideline on Nordic Packages and Q&A document updated

The Nordic Co-operation Group has updated the Guideline on common Nordic packaging materials and the Q&A document. Four new questions have been added to the Q&A document. Some of the existing questions/answers have also been updated.

17.03.2021

EMA Medical terms simplifier

EMA has published Medical terms simplifier – a list of plain-language descriptions of medical terms commonly used in information about medicines.

15.02.2021

Monitoring the adverse reactions of COVID-19 vaccines

On January 27, 2021, Fimea opened a website for adverse reaction reports for coronavirus vaccines. The page is updated more than once a week by the number and severity of adverse reaction reports.

10.02.2021

Great talents joining DRA

Get to know the experts of our growing team. Welcome to Outi, Jaana, Katariina ja Soile.

15.01.2021

International cooperation in evaluating COVID-19 vaccines and drug therapies

EMA has launched a new OPEN pilot to increase international cooperation in evaluating COVID-19 vaccines and drug therapies. The project started in December 2020.

15.01.2021

First notified body approved in Finland

Fimea has approved the first notified body under the new Medical Devices Regulation (MDR), SGS Fimko Oy, in Finland.

21.12.2020

Our team of great colleagues has grown again

Pharmacist specialising in industrial pharmacy Linda Tossavainen-Nikki, MBA and B.Sc. (Pharm.), and pharmacist Anna-Kaisa Tuderman,  M.Sc. (Pharm), are joining our regulatory services team. Sami Tyrjy B.Sc. (Pharm.) has started as a new employee in our sales and marketing team.

26.11.2020

Pharmacovigilance now and in the future – Current topics of the World Drug Safety Congress Europe

Future trends were emphasised strongly in the discussion, especially with regard to the development possibilities introduced by new technological solutions. Read the highlights of the event.

16.11.2020

DRA takes part in the ISPOR Europe 2020 

DRA’s Market Access experts participate in the virtual ISPOR Europe 2020 conference. The theme of the four-day event is Improving Health: Establishing Incentives and Sharing Value.  The aim of the event is to find new perspectives with the global network of HEOR experts on how we establish and share value sustainable for health systems, patients, and technology developers. Virtual ISPOR Europe 2020 will […]

05.10.2020

Growing business requires new kinds of experts

Outi Järvinen, has started work as Head of Resourcing and Accounts in DRA’s sales and marketing team.

1 2 3 14